RVMD

Revolution Medicines, Inc.

37.64 USD
+0.54 (+1.46%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Revolution Medicines, Inc. stock is down -5.97% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 80% of the previous 4 June’s closed higher than May. In the last 9 Unusual Options Trades, there were 8 CALLs, 1 PUT.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
01 May 14:22 17 May, 2024 37.00 CALL 86 216
01 May 19:59 17 May, 2024 39.00 CALL 173 1010
16 May 13:31 17 May, 2024 37.00 CALL 125 304
17 May 14:22 19 Jul, 2024 42.00 CALL 327 0
17 May 19:37 21 Jun, 2024 40.00 PUT 243 2
17 May 19:37 21 Jun, 2024 40.00 CALL 243 3466
22 May 14:06 21 Jun, 2024 46.00 CALL 334 0
10 Jun 15:06 21 Jun, 2024 35.00 CALL 69 2384
13 Jun 15:51 19 Jul, 2024 42.00 CALL 125 332

About Revolution Medicines, Inc.

Revolution Medicines, Inc. focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trials for solid tumors, such as gynecologic and colorectal cancer tumors.